Literature DB >> 356869

Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture.

V R Potter.   

Abstract

Cancer cells should be seen not as exclusively a problem in cell proliferation, but rather as a problem combining the processes of proliferation and differentiation, hence the phrase introduced in 1968: "oncogeny is blocked ontogeny". Cancer tissues resemble foetal tissues in many ways but they differ from foetal tissue in being unable to "recapitulate the total programme leading to an orchestrated collection of organism-serving cells" that are programmed "to make the organ as adaptive as possible to the range of environmental variations in which it evolved". Citing the "Osgood Principle" from the 1950's, recent supporting evidence was described, in which the most mature differentiated cells exert positive and negative feedback upon the proliferation of their progenitor stem cells. Advanced examples in the haemopoietic series were drawn from the work of Sachs, Metcalf, Till and McCulloch, and Kurland and Moore. The blocked ontogeny hypothesis was further elaborated in the concept of "partially-blocked ontogeny", which is intended to describe a situation in which highly differentiated slowly growing tumours contain some cells which have left the proliferating pool to differentiate along the normal pathway, but are blocked somewhere short of the final organism-serving state, in harmony with earlier suggestions by Osgood, by Pierce, and by Sachs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 356869      PMCID: PMC2009671          DOI: 10.1038/bjc.1978.159

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  57 in total

1.  A STOCHASTIC MODEL OF STEM CELL PROLIFERATION, BASED ON THE GROWTH OF SPLEEN COLONY-FORMING CELLS.

Authors:  J E TILL; E A MCCULLOCH; L SIMINOVITCH
Journal:  Proc Natl Acad Sci U S A       Date:  1964-01       Impact factor: 11.205

2.  MODELS AS AIDS TO COMMUNICATION.

Authors:  V R POTTER
Journal:  Natl Cancer Inst Monogr       Date:  1964-04

3.  ON THE RELATIVE FUNCTIONING OF THE PATHWAYS FOR FORMATION OF THYMIDINE NUCLEOTIDES IN THE REGNERATING LIVER AND SPLEEN OF THE RAT.

Authors:  M CRONE; S ITZHAKI
Journal:  Biochim Biophys Acta       Date:  1965-01-11

4.  Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells.

Authors:  A J BECKER; E A McCULLOCH; J E TILL
Journal:  Nature       Date:  1963-02-02       Impact factor: 49.962

5.  Long-term mixed cultures of human hemic cells, with granulocytic, lymphocytic, plasmocytic and erythrocytic series represented.

Authors:  J H BROOKE; E E OSGOOD
Journal:  Blood       Date:  1959-07       Impact factor: 22.113

6.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

7.  Nucleotide interconversions. II. Elevation of deoxycytidylate deaminase and thymidylate synthetase in regenerating rat liver.

Authors:  F MALEY; G F MALEY
Journal:  J Biol Chem       Date:  1960-10       Impact factor: 5.157

8.  An enzymic study on the cellular origin of the Dunning and the Novikoff hepatomas in the rat.

Authors:  H C PITOT; V R POTTER
Journal:  Biochim Biophys Acta       Date:  1960-06-03

9.  A unifying concept of the etiology of the leukemias, lymphomas, and cancers.

Authors:  E E OSGOOD
Journal:  J Natl Cancer Inst       Date:  1957-02       Impact factor: 13.506

10.  Nucleotide interconversions. IV. Activities of deoxycytidylate deaminase and thymidylate synthetase in normal rat liver and hepatomas.

Authors:  F MALEY; G F MALEY
Journal:  Cancer Res       Date:  1961-11       Impact factor: 12.701

View more
  56 in total

1.  Emerging strategies for the identification and targeting of cancer stem cells.

Authors:  Jun Dou; Ning Gu
Journal:  Tumour Biol       Date:  2010-03-25

Review 2.  Hepatic stimulator substance. Discovery, characteristics and mechanism of action.

Authors:  D R LaBrecque
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

3.  Concepts of disease, medical research and the challenges to the schools of the healing professions.

Authors:  E Farber
Journal:  Can Vet J       Date:  1985-04       Impact factor: 1.008

4.  Amplification and invasiveness of epithelial progenitors during gastric carcinogenesis in trefoil factor 1 knockout mice.

Authors:  S M Karam; C Tomasetto; M-C Rio
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

Review 5.  Human adult stem cells as the target cells for the initiation of carcinogenesis and for the generation of "cancer stem cells".

Authors:  James E Trosko
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

Review 6.  The skin: a home to multiple classes of epithelial progenitor cells.

Authors:  Xiaohong Yan; David M Owens
Journal:  Stem Cell Rev       Date:  2008-05-20       Impact factor: 5.739

7.  Tumor promoting properties of a cigarette smoke prevalent polycyclic aromatic hydrocarbon as indicated by the inhibition of gap junctional intercellular communication via phosphatidylcholine-specific phospholipase C.

Authors:  Brad L Upham; Ludek Bláha; Pavel Babica; Joon-Suk Park; Iva Sovadinova; Charles Pudrith; Alisa M Rummel; Liliane M Weis; Kimie Sai; Patti K Tithof; Miodrag Guzvić; Jan Vondrácek; Miroslav Machala; James E Trosko
Journal:  Cancer Sci       Date:  2008-04       Impact factor: 6.716

8.  Commentary: "re-programming or selecting adult stem cells?".

Authors:  James E Trosko
Journal:  Stem Cell Rev       Date:  2008-04-19       Impact factor: 5.739

Review 9.  Neonatal tumours.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2013-10-31       Impact factor: 1.827

10.  Cultured hepatoma cells for the study of enzyme regulation: induction of ornithine decarboxylase by insulin and asparagine.

Authors:  V R Potter; T R Evanson; D P Gayda; J A Gurr
Journal:  In Vitro       Date:  1984-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.